Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
This guide explains how to assess different accounts to maximize yields for your emergency fund in 2026 while maintaining liquidity.
27,516 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A dramatic run in Celcuity shares drew attention from traders and long-term investors alike. This article explains th...
If you are weighing where to invest in the chip sector, this article breaks down how Intel and TSMC differ, what that...
Retirees with seven-figure 401(k) balances face rising RMD pressures. A new, streamlined Roth conversion path is gain...
Gold resumes its ascent in 2026, with three ETFs offering distinct risk paths to access the metal. GLD, GLDM, and GDX...
A surge in crypto funding surging again accompanies a strategic pivot by major VCs toward infrastructure and tokenize...
Global demand for AI-enabled services meets market volatility. This guide breaks down Globant's strategy, risks, and ...
Progressive and Lemonade sit at opposite ends of the insurance spectrum in 2026. This guide breaks down their models,...
In a market crowded with megacaps, an overlooked energy stock may offer outsized upside in 2026. Learn how to spot th...
The 2026 tax rules lift the dependent care credit, easing family budgets as care costs rise. This report explains the...
Powell confirms he will remain as chair pro tem if Warsh is not confirmed by mid-May, delivering a clear answer amid ...
Tired of trying to time the market? This guide shows a simple, proven path: buy solid dividend stocks and hold them f...